Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK

Shah A., Prieto-Alhambra D., Hawley S., Delmestri A., Lippett J., Cooper C., Judge A., Javaid K.

Describe UK regional variation in prescription of anti-osteoporosis drug therapy before and after a primary hip fracture during 1999–2013.

More information Original publication

DOI

10.1007/s00198-016-3530-x

Type

Conference paper

Publisher

Springer Verlag

Publication Date

2016-05-17T00:00:00+00:00

Volume

27